No Data
No Data
One Image Preview | HKEX Q1 performance will be released on Wednesday! The surge in northbound capital drives trading in Hong Kong's market. Will the expectation of returning Chinese concept stocks boost the company's stock price?
UBS Group stated that a 10% change in the average daily trading volume of Hong Kong stocks will cause the Market Cap of the Exchange's Net income in 2025 and 2026 to change by 2.4% and 2.7% respectively, and the revenues of the Exchange in 2025 and 2026 will change by 3.6% and 4.1% respectively.
The "New Shares" Xi'an Dayi Group submitted a listing application to provide radiological surgical solutions.
Xi'an Aida Medical Group today (28th) submitted its application for listing in Hong Kong. Co-sponsors are China Securities Co., Ltd., Pudong Development Bank International, and CMBC CAPITAL. The company is a mainland provider of innovative radiotherapy solutions, and its core product CybeRay is the first real-time image-guided gamma radiotherapy system in the Global market, which received approval from the USA Food and Drug Administration (FDA) in March 2021 and from China's National Medical Products Administration in July 2022. It is currently in the research and development phase for the expansion of indications. The group also has a flagship product TaiChiRT Pro, which is the first in the Global market to obtain FDA breakthrough medical device designation.
The photovoltaic giant JinkoSolar (002459.SZ) has submitted an application for Listed in Hong Kong.
Mainland photovoltaic manufacturer JA Solar Technology Co., Ltd. (002459.SZ) today submitted an application for H Shares Listing to the Stock Exchange. The joint sponsors are CITIC SEC and China International Capital Corporation. According to Frost & Sullivan, the group ranked third globally in photovoltaic module shipments last year, with a market share of 12.3%, and has been among the top four globally in photovoltaic module shipments for ten consecutive years since 2015. As of December 31, 2024, its products cover 178 countries and regions worldwide, and it has established 16 overseas sales companies, including seven regional operation centers in various regions around the world, during which half of its performance record was.
The new stock "Wenjie" Autos manufacturer Chongqing Sokon Industry Group Stock (601127.SH) submitted an application for Listing in Hong Kong.
The automobile manufacturer Chongqing Sokon Industry Group Stock, which holds the 'Wenjie' brand, submitted an application for Listing in Hong Kong to the Stock Exchange today (28th). The joint sponsors are China International Capital Corporation and China Galaxy. Based on today's closing price of 127.25 yuan, its Market Cap reaches 207.8 billion yuan. So far, the group has successfully launched four models: Wenjie M5, Wenjie M7, Wenjie M8, and Wenjie M9. The total delivery volume of the Wenjie brand reached 0.3871 million vehicles last year, representing a year-on-year growth of 268%. Chongqing Sokon Industry Group Stock's revenue increased 3.05 times year-on-year to 145.112 billion yuan; turning profit from loss.
Express News | The Hong Kong Stock Exchange: JPMorgan's long position in BEIGENE increased from 8.57% to 9.07% on April 22.
Goldman Sachs: The acquisition of headquarters property by HKEX can strengthen brand image, with a Target Price of 378 HKD.
Goldman Sachs released a research report stating that HKEX (00388) announced the purchase of the Central Trading Square property to serve as its permanent headquarters. It is believed that the acquisition of headquarters property by HKEX will help strengthen its role as an important component of Hong Kong's financial market infrastructure, as well as its brand image as a vital exchange connecting the East and West. The target price is set at HKD 378, with a rating of "Buy."